Get the Stockscreener App
12.29
4.47%
-0.575
After Hours:
12.45
0.165
+1.34%
Caredx Inc stock is traded at $12.29, with a volume of 1.24M.
It is down -4.47% in the last 24 hours and down -37.13% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$12.86
Open:
$12.71
24h Volume:
1.24M
Relative Volume:
0.81
Market Cap:
$684.04M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-4.5669
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-4.32%
1M Performance:
-37.13%
6M Performance:
-47.27%
1Y Performance:
-38.54%
1-Day Range:
$12.24
$12.79
1-Week Range:
$12.24
$13.29
52-Week Range:
$10.96
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
12.29 | 716.05M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx launches AI-driven AlloSure Plus integrated with EPIC Aura - Investing.com Australia
CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress - Business Wire
CareDx Just Settled With Investors Over Medicare Billing Misconduct— Here’s How To Get Your Payout - TradingView
Why CareDx Inc stock attracts strong analyst attentionProfit Target Stock Opportunity Monitor Activated - metal.it
A Year into the Role, John Hanna is Setting a Clear Course at CareDx - The Healthcare Technology Report.
CareDx Inc Breakout Confirmed by Volume MetricsLow Capital High Return Stock Plans Reviewed - metal.it
CareDx rebounds as draft LCD suggests no change in coverage - MSN
Published on: 2025-07-29 01:35:58 - metal.it
CareDx Inc Sees Spike in Bullish Option FlowSecure Return Focused Investment Plan Released - metal.it
What are the technical indicators suggesting about CareDx IncGet exclusive market analysis for investors - jammulinksnews.com
What are analysts’ price targets for CareDx Inc in the next 12 monthsFinancial News Report That Work - jammulinksnews.com
What is CareDx Inc company’s growth strategyBoost your returns with professional guidance - jammulinksnews.com
How does CareDx Inc compare to its industry peersBuild a portfolio that outperforms the market - jammulinksnews.com
How many analysts rate CareDx Inc as a “Buy”Dynamic profit expansion - jammulinksnews.com
What are the latest earnings results for CareDx IncRemarkably fast returns - jammulinksnews.com
When is CareDx Inc stock expected to show significant growthDiscover market opportunities with real-time data - jammulinksnews.com
What makes CareDx Inc stock price move sharplyFree Real-Time Market Predictions - metal.it
How CareDx Inc stock performs during market volatilityTargeted 200 Percent Gain - metal.it
Will CareDx Inc stock benefit from AI tech trendsRapid portfolio appreciation - jammulinksnews.com
What drives CareDx Inc stock priceGame-changing returns - Autocar Professional
CareDx Settlement Approved — Here’s How to Get Your Share - TradingView
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 32% - simplywall.st
CareDx to Report Second Quarter 2025 Financial Results | CDNA St - GuruFocus
CareDx To Report Second Quarter 2025 Financial Results - Barchart.com
ADF GROUP INC. ANNOUNCES THE SIGNING OF A MAJOR LONG-TERM CONTRACT IN QUEBEC'S ENERGY SECTOR, WHICH AT MATURITY, COULD TOTAL CLOSE TO $400 MILLION - The Globe and Mail
What analysts say about CareDx Inc stockPhenomenal capital gains - jammulinksnews.com
Is CareDx Inc a good long term investmentHigh-impact stock picks - jammulinksnews.com
CareDx Inc Stock Analysis and ForecastPowerful profit generation - jammulinksnews.com
CareDx (NASDAQ:CDNA shareholders incur further losses as stock declines 33% this week, taking five-year losses to 60% - Yahoo Finance
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains? - Nasdaq
How to Take Advantage of moves in (CDNA) - news.stocktradersdaily.com
Buying the Dips in 2 Diagnostic Names After 'Significant Overreactions' - TheStreet Pro
CareDx's Strategic Positioning in the Evolving Transplant Diagnostics Market: Reinforcing Revenue Stability and Long-Term Growth - AInvest
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):